Amy Robach Updates ‘Good Morning America’ On Cancer Spread: Video

Amy Robach Updates ‘Good Morning America’ On Cancer Spread: Video

Good Morning America interviewed ABC News’ Amy Robach this morning — three weeks after her double mastectomy and coinciding with her People magazine cover — to tell viewers she will undergo four months of chemo after her mastectomy revealed the cancer had spread to her lymph nodes, as well as a second malignant tumor. “I’m going to work through it,” she said of the chemo, which she will begin later this month. “I saw Robin [Roberts] do it. I know how strong you were and you give me strength, Robin, because it is important to get up and have something to do each day,” she told the GMA on-air gang. Here’s a clip of Robach’s interview:

Robach’s cancer diagnosis after an on-air mammogram made news. American TV viewers have become accustomed to watching news talent having various on-air health checkups since Katie Couric’s on-air colonoscopy more than a decade ago; last month on NBC’s Today, Matt Lauer and Al Roker got on-air-but-behind-doors prostate exams.

Robach got her very first mammogram on Good Morning America in October, as talent across the morning infotainment-show landscape plugged Breast Cancer Awareness Month. What viewers are not used to is that correspondent announcing, not long thereafter, that they have breast cancer and will have a double mastectomy. On GMA and in a post on ABC.com, Robach said the mammogram was something she had agreed to do only at the request of a GMA producer, for the show’s Breast Cancer Awareness Month programming. The cancer concerns were not raised during that broadcast; viewers learned a few weeks later she had cancer and decided to have the double mastectomy.

Related stories

ABC News’ Amy Robach: Double Mastectomy Revealed Second, Undetected Malignant Tumor

ABC News’ Amy Robach To Have Double Mastectomy After On-Air Mammogram Leads To Cancer Diagnosis

Sam Champion Leaves ‘Good Morning America’ For Weather Channel, Ginger Zee To Replace Him

Get more from Deadline.com: Follow us on Twitter, Facebook, Newsletter